EU PPWR Compliance for Medical Device Packaging: Top Questions Answered

The EU Packaging and Packaging Waste Regulation (PPWR), Regulation (EU) 2025/40, entered into force on 12 August 2026. Many medical device manufacturers have read the basic regulation introduction, yet practical questions remain: What makes a test report valid? Can sterile packaging really be exempted? Can your MDR Authorised Representative directly act as the PPWR responsible person? Can a RoHS report be used in an emergency? Does shipping logistics packaging fall under control?

Based on real inspection requirements for manufacturers, this article answers the most frequently asked PPWR questions for medical device exporters — covering testing, responsible persons, EPR, technical documentation and exemption boundaries — so you can avoid packaging compliance pitfalls and prevent goods being held at customs despite complete MDR documentation.

Original source: WeChat public account "施德莱普检测认证" (ShiDeLaiPu Testing & Certification), published 24 June 2026. Reprinted with the original information retained. Original article: //mp.weixin.qq.com/s/qIPxraJkhy0pVrSW8F6Plg

1. Material Test Reports

Q1. What is the PPWR heavy metal limit, and which packaging components need testing?

The regulation requires the sum of lead, cadmium, mercury and hexavalent chromium to be ≤ 100 mg/kg. There is no "main packaging exemption" — every packaging component must be individually assessed and tested. The scope covers not only cartons and retail boxes but also sealing tape, self-adhesive labels, printing inks, lamination/coating layers, varnish, bubble film, EPE foam, packing buckles, desiccant pouches and other components.

Key reminder: mixed-material testing is strictly prohibited. Cartons, plastic film, tape and ink are different homogeneous materials and must be sampled and tested separately. Data from mixed samples is invalid and will not be accepted by customs. Many companies test only the carton itself and ignore tape and ink, directly causing the entire batch to be judged non-compliant.

Q2. What qualifications must the laboratory have? Can ordinary third-party reports be used?

The issuing laboratory must hold ISO/IEC 17025 accreditation. Reports from SGS, TÜV, Intertek, BV, CTI and similar accredited bodies are accepted. Reports issued by non-accredited organisations are directly deemed invalid by EU regulators, importers and customs.

The sample name and material description on the report must correspond one-to-one with the materials actually purchased and used. Generic template reports or reports with vague material descriptions that cannot be matched to the actual goods have no evidentiary value for compliance.

Q3. I have a RoHS report — can I use it directly as a PPWR test report?

It cannot directly replace a PPWR report, but the data can serve as temporary emergency reference. RoHS controls electronic and electrical whole-machine components with item-by-item limits, while PPWR targets packaging and mandates the sum of four heavy metals ≤ 100 mg/kg. Even if every RoHS item passes, the four-item total can still exceed 100 mg/kg.

RoHS reports do not state a clear four-item sum conclusion, so customs review can easily question the inconsistency. If the report is whole-machine mixed testing, it cannot be used for packaging compliance evidence at all.

Practical advice: an existing RoHS report can be used as temporary supporting evidence; when commissioning a laboratory later, explicitly request a packaging-specific test report issued against the 94/62/EC and PPWR heavy metal total requirements — dedicated packaging testing is often cheaper.

Q4. Do sterile medical device packaging need PFAS testing?

The PPWR mandatory PFAS limit applies only to food-contact packaging; sterile packaging for medical devices is outside the mandatory scope. However, if the customer's import contract explicitly requires PFAS compliance, we recommend requesting a PFAS compliance declaration from the packaging supplier as forward-looking risk mitigation. Inks, adhesives and coatings must still meet the heavy metal total limit.

2. Exemption Boundaries for Medical Device Packaging

Q5. My product uses sterile medical device primary barrier packaging — can all PPWR requirements be exempted?

There is no blanket exemption — only two provisions offer limited exemptions; all other obligations are mandatory. Sterile barrier packaging (dialysis paper, paper-plastic pouches, blister packs) may be exempt from:

• Mandatory recyclability grading assessment for packaging
• Minimum recycled content requirement for primary plastic packaging

Obligations that can never be exempted: the four-heavy-metal total limit, EPR registration and declaration, packaging DoC declaration of conformity, the full packaging technical documentation, and recycling labelling (packaging with no print space may enjoy a limited label-printing exemption, but information must still be retained via a digital medium).

Important: secondary sales cartons, blister film, tertiary logistics outer boxes, cushioning foam and sealing tape enjoy no exemption at all — every PPWR provision must be fully implemented. Many medical device companies fall into this trap by testing only sterility while ignoring transport packaging materials.

Q6. Are logistics shipping cartons, stretch film and pallets used only for delivery subject to PPWR?

All are controlled. Any packaging that accompanies medical devices into EU territory — whether sales packaging or purely transport logistics packaging — falls within PPWR scope. There is no "transport packaging exemption". Corrugated outer boxes, stretch film, EPE, pearl cotton, paper corner guards and strapping bands all require material assessment and testing, and must be included in the packaging BOM.

3. Responsible Persons, EPR Registration, and the Relationship with MDR / EU Authorised Representative

Q7. I already have an MDR EU Authorised Representative — can they directly serve as the PPWR packaging compliance responsible person?

These are two independent legal systems and cannot be automatically reused or covered. At the legal level you may commission the same organisation, but a separate written PPWR mandate agreement must be signed — the MDR Authorised Representative agreement cannot directly serve as the PPWR Authorised Representative mandate document.

Under PPWR there are two distinct responsible entities:

• PPWR Technical Authorised Representative (EU-AR): liaises with customs authorities, keeps packaging technical documentation, and handles DoC technical coordination;
• EPR extended producer responsibility person: handles waste-recovery registration and annual declarations and fees in each member state.

The MDR Authorised Representative does not automatically assume either obligation — always confirm the service scope separately.

Q8. What is EPR registration? When is it mandatory? Is there a shipment volume threshold?

Any packaging placed on the market in an EU member state requires EPR registration. There is no annual tonnage exemption; only volumes below 10 tonnes may use a simplified declaration process.

Regular trade with an EU local importer: the importer, as the local legal producer, completes EPR registration; the Chinese factory provides the full packaging BOM, material and weight data, and keeps the registration number on file for audit.

Cross-border direct sales (independent sites, Amazon, without an EU local importer): the Chinese medical device manufacturer is the legal responsible entity and must commission an EU PPWR responsible person to handle EPR registration in each target sales country. Without an EPR registration number, products may be delisted from platforms or detained and returned at port.

Tip: EPR is registered per country — registrations must be filed separately, and one registration cannot cover all 27 EU member states.

4. DoC Declaration of Conformity, Technical Documentation and Labels

Q9. How many PPWR packaging DoC declarations are needed? Who signs them?

Number of DoC documents: independent packaging categories with different materials/structures/uses each require a separate PPWR DoC; packaging with the same formulation, material composition and use scenario may be combined into a single DoC without duplication.

Signing entity and legal responsibility: whoever places the product on the EU market and sells it under their own brand is the legal manufacturer, and that company's authorised responsible person signs and stamps the DoC. Signing is equivalent to a legal guarantee that the packaging fully meets PPWR environmental compliance requirements — if compliance problems arise, the signing company bears all EU legal penalties, recalls and detention liability.

Q10. How long must the full PPWR technical documentation be kept? What does the file contain?

For single-use medical device packaging, technical documentation must be kept for 5 years; for reusable/returnable packaging, 10 years. When regulators request materials, companies must provide the complete file within the required timeframe.

Required archive checklist:

• Complete packaging BOM bill of materials, breaking down every packaging component;
• Third-party test reports for each homogeneous material;
• Supplier declarations of hazardous substance compliance;
• PPWR Authorised Representative mandate agreement;
• EPR registration certificates and registration numbers for each target country;
• PPWR packaging DoC declaration of conformity;
• Packaging drawings and label design files, plus exemption basis documents (when exemption clauses are used for sterile packaging, a written exemption justification must be retained).

Q11. When is the packaging recycling label mandatory? What if medical device packaging has no room to print the label?

The unified recycling classification label becomes mandatory on 12 August 2028. At the current stage printing is not yet mandatory, but label redesign planning should start early.

If medical device packaging already carries UDI barcodes, sterilisation marks and CE marks with no spare print space, it may enjoy a limited label-printing exemption — but packaging compliance information must still be retained via a digital medium. This is not a full exemption from compliance obligations.

Q12. What is over-packaging, and what should medical devices watch out for?

Packaging void-ratio control becomes mandatory on 1 January 2030: the void ratio of grouped/transport packaging must be ≤ 50%, and sales packaging may only retain the space necessary for product protection. Large boxes holding small devices, artificially thickened box walls and excessive foam filling are prohibited.

Although enforcement has not yet started, companies should evaluate early during packaging redesign to reduce the cost of large-scale repackaging later.

5. Risk and Practical Pitfalls Review

Q13. What are the actual consequences of PPWR non-compliance?

• Customs container inspection leads to direct detention of goods, demurrage and warehousing costs, and in serious cases forced return or destruction;
• EU market surveillance spot checks find non-compliance and require products to be delisted across all channels;
• Unregistered EPR leads to cross-border e-commerce platform listing delisting;
• The company is placed on a high-risk operator list, increasing the probability of container inspection for every subsequent shipment;
• Member states impose high administrative fines, with importers and the PPWR Authorised Representative bearing joint legal liability.

Q14. The same packaging material with only updated print artwork — does it need retesting?

If the material, supplier and adhesive/ink formulation are unchanged and only the visual artwork is adjusted, the original ISO 17025 test report remains valid. If the ink formulation, adhesive or packaging raw-material supplier is changed, the corresponding components must be re-tested.

Q15. Does every shipment need a new test report?

With the same supplier, same material and same process, test reports remain valid continuously — repeated batch testing is not required. Companies should manage supplier-change control: the moment materials change, immediately re-assess and re-test.

Conclusion

PPWR compliance is not a matter of simply completing a few test reports — it is a systematic compliance effort covering material testing, responsible-person appointment, EPR registration, DoC declarations and complete technical documentation. The limited exemption clauses in the medical device industry are easily misread: many companies assume sterile packaging is fully exempt and ignore heavy metal control, EPR registration and technical documentation retention, burying major customs-clearance risks.